# Autologous Endothelial Progenitor Cells (EPCs) From Peripheral Blood in the Treatment of Critical Limb Ischemia

> **NCT01595776** · PHASE1,PHASE2 · COMPLETED · sponsor: **Fondazione IRCCS Policlinico San Matteo di Pavia** · enrollment: 8 (actual)

## Conditions studied

- Critical Limb Ischemia

## Interventions

- **OTHER:** Endothelial progenitor cells intramuscular implant

## Key facts

- **NCT ID:** NCT01595776
- **Lead sponsor:** Fondazione IRCCS Policlinico San Matteo di Pavia
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2012-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01595776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01595776, "Autologous Endothelial Progenitor Cells (EPCs) From Peripheral Blood in the Treatment of Critical Limb Ischemia". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01595776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*